logo
logo

Anabios Closes Financing With Ampersand Capital Partners

Jun 07, 2022•over 3 years ago
San DiegoCommunity And Lifestyle

Description

AnaBios Corporation, a leading preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue, today announced an investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.

Company Information

Company

Ana Bios

Location

San Diego, California, United States

About

As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis. "AnaBios is thrilled to partner with Ampersand to elevate our business in the growing pharma industry," said Dr. Andre Ghetti, CEO of AnaBios.